Blog
Insights on data analysis, AI, and the platform we're building at Portrai.
Latest
252 articles[Dummy] A Deep Dive into AI-Driven Drug Discovery Pipelines (455)
Single-cell analysis is the starting point for understanding cellular heterogeneity. Best practices updated as of June 25, 2026: - Setting QC metrics and handling outliers - Correcting batch…
[Dummy] Understanding Immunotherapy Response Prediction Models (378)
Spatial transcriptomics is a powerful tool for understanding cell-cell interactions while preserving the positional context of gene expression.
[Dummy] A Deep Dive into AI-Driven Drug Discovery Pipelines (1467)
Single-cell analysis is the starting point for understanding cellular heterogeneity. Best practices updated as of June 24, 2026: - Setting QC metrics and handling outliers - Correcting batch…
[Dummy] New Approaches to Tumor Microenvironment Analysis (827)
Single-cell analysis is the starting point for understanding cellular heterogeneity. Best practices updated as of June 24, 2026: - Setting QC metrics and handling outliers - Correcting batch…
[Dummy] A Practical Guide to Interpreting Single-Cell Data (1908)
AI-driven drug discovery accelerates the entire process, from target identification to candidate optimization. In this article we cover: 1. Data preparation and quality control 2.
[Dummy] Data-Driven Target Discovery Strategies (1225)
AI-driven drug discovery accelerates the entire process, from target identification to candidate optimization. In this article we cover: 1. Data preparation and quality control 2.
[Dummy] Data-Driven Target Discovery Strategies (890)
Spatial transcriptomics is a powerful tool for understanding cell-cell interactions while preserving the positional context of gene expression.
[Dummy] The Future of Precision Medicine with Spatial Transcriptomics (698)
Single-cell analysis is the starting point for understanding cellular heterogeneity. Best practices updated as of June 23, 2026: - Setting QC metrics and handling outliers - Correcting batch…
[Dummy] Understanding Immunotherapy Response Prediction Models (583)
AI-driven drug discovery accelerates the entire process, from target identification to candidate optimization. In this article we cover: 1. Data preparation and quality control 2.
WRITTEN BY
Portrai's Authors
Capturing and compounding Portrai's insights.
[Dummy] Arjun Patel
Senior Research Scientist
Drug discovery scientist bridging machine learning and target validation.
[Dummy] Daniel Cho
Chief Scientific Officer
Spatial biology researcher focused on translating imaging biomarkers into next-generation therapeutics.
[Dummy] Elena Rossi
Chief Scientific Officer
Genomics specialist with a decade of experience in multi-omics data integration.
[Dummy] Hyung-Jun Im
VP of Research
Nuclear medicine physician-scientist working at the intersection of AI and imaging.
[Dummy] Jae-Won Park
VP of Research
Nuclear medicine physician-scientist working at the intersection of AI and imaging.
[Dummy] Mei Lin
VP of Research
Genomics specialist with a decade of experience in multi-omics data integration.
[Dummy] Rahul Verma
Senior Research Scientist
Computational biologist building scalable pipelines for single-cell and spatial omics analysis.
[Dummy] Yuki Tanaka
Bioinformatics Lead
Genomics specialist with a decade of experience in multi-omics data integration.